Trial intelligence / Profile preview

17-Beta Estradiol for Puberty Induction in Turner Syndrome

NCT01710696Phase 3Completed

Sponsor
Novo Nordisk
Start
Jul 1998
Primary completion
Jul 2004
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 3 trial of estradiol in Turner syndrome (TS), sponsored by Novo Nordisk. Started Jul 1998; status: completed.

02

Drugs

estradiol
03

Conditions

Turner syndrome (TS)

Beyond the preview

Go deeper on NCT01710696.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01710696.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call